Skip to content

Effect of dietary intervention on cardiovascular risk factors in patients with hypertension complicated with obesity

Effect of dietary intervention on cardiovascular risk factors in patients with hypertension complicated with obesity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068915
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Obese patients with hypertension (BMI >= 28 kg/m^2) were diagnosed by Yongshun Community Health Service Center of Tongzhou District, Beijing, and their blood pressure was controlled at 130-160mmHg. 2. Aged between 18 and 75 years (inclusive). 3. Currently taking antihypertensive drugs on a regular basis. 4. The patients (or legal guardians) understood the research requirements and treatment procedures and signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction or cerebrovascular event (including cerebral hemorrhage, cerebral infarction and TIA) in the last 6 months. 2. Poor medication compliance or poor blood pressure measurement compliance. 3. Alcohol abuse or are currently on a diet or other special diet. 4. People who eat three meals a day irregularly or have poor chewing ability. 5. People who are taking hypoglycemic drugs, receiving insulin therapy, or have unstable blood sugar control. 6. Complicated with other organ failure, such as severe renal insufficiency (GFR?), etc. 7. Have a serious disease with a life expectancy of less than 12 months, such as malignancy, advanced disease, etc. 8. People who suffer from mental illness, cognitive impairment, memory impairment, severe visual/hearing impairment, or other unforeseen reasons that prevent them from receiving intervention. 9. People during pregnancy or puerperium. 10. People with unstable lipid control, or newly added lipid-lowering treatment and taking lipid-lowering drugs within 1 month. 11. Increased medication or changed medication regimen due to metabolic diseases within the last 6 months or during the intervention period.

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure;Diastolic pressure;

Secondary

MeasureTime frame
Body mass index;Waist circumference;Blood glucose;Blood lipid;Uric acid;

Countries

China

Contacts

Public ContactHuang Rongchong

Beijing Friendship Hospital, Capital Medical University

rchuang@aliyun.com+86 188 4118 2000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026